Tag Archives: diabetes

New Study of Chicago ER Patients Reveals Troubling Findings on Diabetes – NBC Chicago

Diabetes News

A new study published in the JAMA Network by UI Health staff found hundreds of unsuspecting patients had diabetes and prediabetes, that left untreated could lead to major complications down the road.

“What’s novel about this is that we’re conducting a preventative health screening within our emergency department. So most people that are coming to the emergency department are not coming in because they want to be screened. But we also know that diabetes is of high prevalence within our community,” Dr. Janet Lin said, an ER physician who helped implement the diabetes screenings.

For three months starting in February 2021, UI Health randomly screened more than 2,000 ER patients who met criteria for a diabetes screening.

Of the 2,074 screened, 52.3% had an abnormal A1C result. A stunning number, but that isn’t what shocked doctors the most.

“70% of the people that basically had an abnormal test, in aggregate, did not know that they were either prediabetic, or diabetic,” Dr. Lin said.

Of those 1,085 patients with abnormal results, 69.9% were prediabetic and 30.1% were diabetic. Among those patients, 62 had severe diabetes, which could be life-threatening.

“If it goes uncontrolled, it will lead to a lot of complications that include stroke, heart attacks, kidney failure, loss of limbs, loss of vision,” Dr. Lin said.

Dr. Lin and the study authors say this should be a wake up call that diabetes screenings are important, and often consist of a simple blood test.

The American Diabetes Association recommends anyone over the age of 45 be screened for diabetes every three years. People between the ages of 18-44, with a BMI greater than 25, which is an indication of obesity, should also be screened every three years as well.

UI Health has continued the diabetes screening beyond the pilot study that lasted three months and they’re seeing similar results. On average, they are diagnosing 300 people every month with prediabetes or diabetes, through the emergency room screenings.

When coordinators called one of the first patients who was found to have prediabetes, Dr. Janet Lin said he answered the phone right away and was very surprised by the results.

“He said, “What?” And he’s like, you know, I’m in line at the McDonald’s. I was just about to buy a Big Mac or some other thing. He’s like, I am not going to get a Big Mac, please tell me how I can actually help change my lifestyle,” Dr. Lin said.

Patients are referred for further care, a win for the medical community that is working hard to fight what is often called a silent disease.

“This is an opportunity for us to be able to screen for people that might not otherwise get screened,” Dr. Lin said.

Source link

Juvenile Diabetes Research Big Winner in Ford’s $490K Mustang Auction

Diabetes News
2024 Ford Mustang

The gavel fell on bidding for the first 2024 Ford Mustang GT off the line, VIN 001, at Barrett-Jackson’s Scottsdale, Arizona, auction tonight with a sale price of $490,000.

Proceeds from the auction of the seventh-generation sports car benefit the Juvenile Diabetes Research Foundation (JDRF).

Ford has a long tradition of supporting charities through the Barrett-Jackson auction, and we’re proud to offer the all-new Mustang GT to support worthy causes like juvenile diabetes research,” said Mustang Marketing Manager Jim Owens.

Ford Motor Company’s history of auctioning off VIN 001 vehicles to benefit the charity. has resulted in millions of dollars being raised to benefit JDRF.

A 2021 Ford Mustang Mach 1 in Fighter Jet Gray went for $500,000. The previous year, a 2020 Ford Mustang Shelby GT500 was driven onto the auction block by Carroll Shelby’s grandson Aaron Shelby and Edsel Ford II. That model sold for $1.1 million to Craig Jackson, the Chairman and CEO of the auction.

1 of 10

A Wimbledon White and blue 2016 Ford Mustang GT350R brought down the gavel for $1,000,000. A year before that, North Texas dealer Sam Pack purchased the first retail production unit of the sixth-generation Mustang GT for $300,000.

Ford Motor Company’s relationship with the charity dates back to 1983 when the automaker sponsored a fundraising walk in Dearborn, Michigan, near the company’s headquarters.

The affiliation turned personal in 1997 when the son of Edsel Ford II and great-grandson of Ford founder Henry, Albert, was diagnosed with Type 1 diabetes.

The following year an employee-driven Ford Global Walk Team was formed, with Edsel Ford II leading the charge.

In 2015, the Metro Detroit and Southeast Michigan Chapter of JDRF received a $1 million gift from Cynthia and Edsel Ford II.

The next-generation Mustang GT, the most powerful in company history, debuted in September. The car’s 5.0-liter V8 engine delivers 486 horsepower and 418 pound-feet of torque. Either a six-speed manual or 10-speed automatic transmission is available.

Mustang GT buyers can get the model with the optional Performance Pack, which adds Recaro seats and an active exhaust to the American sports car.

The electronic drift brake allows rear-wheel drive drifting capability.

The winning Mustang GT bidder will be able to choose from any of the standard Mustang GT fastback options, which includes 11 exterior colors, 18 to 20-inch alloy wheels and Brembo brakes (three colors available). Interior packages and the Performance Pack are also options.

The new Mustang is expected to reach dealerships this summer. Pricing for models from VIN 002 and up has not been revealed.

Source link

City Council health chair announces citywide diabetes plan

Diabetes News

City Council Committee on Health chair Lynn Schulman, a Queens Democrat, announced the Council will be proposing a citywide diabetes reduction plan this year.

“It’s something that the city really hasn’t focused on,” Schulman said. “We need to go into communities with culturally competent education materials.”

The councilmember said the plan will be based on the 90-90-90 strategy developed by the United Nations to tackle the AIDS epidemic. Schulman added she has been in conversation with city Health Comissioner Dr. Ashwin Vasan about her proposal.

Schulman also discussed the City Council’s health goals in 2023 and her views on how the city should take on unlicensed cannabis shops.

Source link

Study suggests COVID-19 can cause diabetes

Diabetes News
Study: New-Onset Diabetes and COVID-19: Evidence from a Global Clinical Registry. Image Credit: ADragan / Shutterstock

The authors of a new study under review at Nature Portfolio and currently posted to the Research Square preprint* server showed the clinical possibility that the coronavirus disease 2019 (COVID-19) heightens the risk of developing diabetes mellitus (DM), supporting diabetes screening in those infected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). 

Study: New-Onset Diabetes and COVID-19: Evidence from a Global Clinical Registry. Image Credit: ADragan / ShutterstockStudy: New-Onset Diabetes and COVID-19: Evidence from a Global Clinical Registry. Image Credit: ADragan / Shutterstock


An increasing body of evidence suggests that COVID-19 is associated with new diabetes diagnoses. However, it is unclear whether COVID-19 detects pre-existing diabetes or induces new-onset diabetes.

Although previous research reported high blood-sugar levels and metabolic consequences resulting from pre-existing diabetes following COVID-19 hospitalization, studies correlating the disease to new-onset DM are scarce.

COVID-19 has been shown to exacerbate pre-existing diabetes. This likely occurs because COVID-19 is associated with low-grade inflammation, which may initiate or worsen insulin resistance. In addition, numerous studies have also demonstrated that SARS-CoV-2 can infest and multiply within insulin-producing pancreatic beta-cells, thus impairing insulin synthesis and secretion. 

However, whether SARS-CoV-2 can cause clinically meaningful changes in glucose metabolism remains unclear. Nevertheless, it may be possible to find an answer by characterizing the clinical symptoms of COVID-19-related diabetes and by determining the period between the onset of hyperglycemia and that of the infection.

It is imperative to establish a causal relationship between COVID-19 and diabetes since both diseases are prevalent throughout the world. Furthermore, establishing a causal relationship will have significant implications for diagnosis, management, public health, and scientific research. Despite this, it remains unclear whether the association between COVID-19 and diabetes results from indirect health consequences of the former, such as – a higher rate of detection of pre-existing diseases, or whether the causative virus (SARS-CoV-2) directly precipitates hyperglycemia. 

Owing to the higher rate of pre-existing disease detection in the COVID era, newly diagnosed diabetes may be explained both during and after an episode of infectious exposure.

The study

This study investigated the possibility that COVID-19 may trigger new-onset diabetes and its associated symptoms by examining average blood-glucose levels at the time of diabetes presentation against a global clinical registry.

A global COVID-19-related diabetes (CoviDIAB) registry was established to determine whether COVID-19 can acutely induce diabetes and its clinical symptoms. The CoviDIAB registry collects information regarding “newly diagnosed diabetes” and “severe metabolic complications associated with pre-existing diabetes” resulting from COVID-19. 

Individuals with a fasting blood glucose of 126 mg/dL or above or non-fasting blood glucose of 200 mg/dL or above, with no prior diabetes history, and those who had never been on glucose-lowering medications, and with their glycated hemoglobin (HbA1c) levels below the diabetic range (< 6.5%) at presentation were categorized as new-onset diabetes. Here, the researchers examined cases of newly diagnosed diabetes that occurred within four weeks of COVID-19 confirmation. In addition, the HbA1c data were evaluated at the time of diabetes detection to rule out pre-existing hyperglycemia and to confirm the association with SARS-CoV-2 infection.

The findings

Data on 537 eligible newly diagnosed diabetes cases was entered from 61 hospitals in 25 countries between 2020-2022. COVID-19 patients with newly diagnosed diabetes at presentation had HbA1c levels above the diagnostic range, suggesting pre-existing hyperglycemia.

In cases with new-onset hyperglycemia after the SARS-CoV-2 infection, individuals displayed glycemic levels above the diagnostic thresholds, although their HbA1c levels remained within the non-diabetic range. The results showed that 22% of newly diagnosed patients with documented HbA1c levels had recently acquired diabetes.

The most common diabetes subtype among adults was type 2 DM (59%), and the “not yet known” subtype (41%). Two newly diagnosed cases of type 1 DM were recorded among children. After COVID-19 resolution, hyperglycemia persisted in 39 of 89 patients (45%) with newly diagnosed diabetes.

For 28 of these individuals, follow-up data beyond three months was collected, demonstrating that five of them were in remission from diabetes, while 23 (82%) remained diabetic. 

The findings suggested that COVID-19 causes clinically significant changes in glucose metabolism. Although this study does not prove that SARS-CoV-2 causes diabetes, it strongly suggests that the virus may impose a diabetogenic aftermath. 

Further, type 2 DM was the predominant subtype among COVID-19 participants with newly diagnosed diabetes. Thus, type 2 DM likely accounts for most newly diagnosed diabetes cases associated with the post-acute phase of the SARS-CoV-2 infection.

This study confirms this phenomenon across diverse geographical locations and ethnicities by incorporating clinical observations from 25 countries. 

Numerous areas for improvement have been identified in this study, including inherent heterogeneity in clinical practice and the judgment of contributing physicians. 


The results of this study suggest that COVID-19 likely has a diabetogenic effect. Thus, individuals exposed to SARS-CoV-2 infection must be screened for diabetes. Further research is necessary to confirm the mechanisms through which the virus interferes with glucose metabolism.

*Important notice

Research Square publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Source link

Are people with diabetes more likely to have osteoporosis, bone fractures?

Diabetes News
bone health

The woman sitting across the table was distressed. She was 60 years old and had diabetes for 20 years. “Two months ago, I developed a bout of coughing, followed by a sharp back pain. The doctor asked for an X Ray and told me that I had fractured my spine! Nothing hit me, I did not fall. It was just a bad coughing spell. How did I break my vertebra?” The pain was severe for a few weeks but gradually settled and she was then allowed to move around with a brace. The woman had osteoporosis, a condition characterised by porous, fragile bones, which break with minimal or no trauma. Usually, weak bones do not result in pain unless they break, and a fracture is often the first clinical symptom.

What is osteoporosis?

Our skeleton provides a frame for our body and protection for the organs within, much like the metal beams and girders that support buildings. Like metal, bones also suffer wear and tear. Unlike metal, however, bones are living tissues and have a remarkable capacity to regenerate and heal. Sites of minor damage are constantly replaced by new, healthy bones. When the capacity of the body to form new bone is unable to keep up with bone loss, there is progressive weakening, resulting in osteoporosis.

During childhood and adolescence, our skeleton grows rapidly. Enabled by vitamin D, the skeleton builds its calcium stores, particularly during puberty. Boys have bigger bones than girls, and accumulate more minerals over a longer period of time. From the age of 30, we begin to lose bone gradually, a process that is accelerated at menopause in women. If left unchecked, this loss gradually weakens the bones, making them brittle and resulting in fractures. Typically, fractures due to osteoporosis occur at the hip, spine, shoulder or wrist and can have a life-changing impact.

Why are diabetics at greater risk of bone fractures?

People with diabetes have a greater risk of breaking their bones. In those with childhood onset, insulin-dependent type 1 diabetes, this risk is increased by two to four-fold. In those with type 2 diabetes, the risk of fracture is 30-50 per cent higher as compared to those without diabetes. We know that diabetes can result in several chronic complications, involving the heart, kidney, eyes and nerves. Fragility fractures can be regarded as a consequence of diabetes too.

Typically, it requires about 10 years (minimum five years) of diabetes to impact fracture risk. Poorly-controlled diabetes with complications confers a greater risk of fracture. Importantly, people with diabetes fracture at a higher bone density than those without diabetes. The T score is a number shown on the DXA bone density report. Typically, fracture risk is thought to increase if the bone density shows a T score of below -2.5, whereas in diabetes this figure is -2. This means that people with diabetes may require intervention earlier, maybe at a T score of -2 rather than -2.5. If they get a fracture, people with diabetes take longer to recover and have poorer outcomes, particularly after hip fracture.

Why are people with diabetes more prone to osteoporosis?

First, people with uncontrolled, long-standing diabetes have poor quality bones, which fracture easily. Second, they have lower muscle mass, which indirectly impacts their bone strength, and also makes them more prone to falling and breaking a bone. Third, older people with diabetes often have associated visual issues or nerve-related issues, which again put them at greater risk of falls and fractures.

How can people with diabetes reduce their risk of fractures?

1) Testing : People with diabetes should get their bone density checked at the age of 50 if they have had diabetes for more than 10 years. For those over 60, it makes sense to have your bone density checked anyway. A T score of below -2 requires attention. Your doctor will decide if you need medication or not. However, routinely checking BMD in younger people – below the age of 50 – is NOT recommended, even if they have diabetes.

2) Control your sugars: Good control of diabetes will protect your bones along with other organs.

3) Calcium: An adequate calcium intake is a must for our bones and dairy products are the main source of calcium. If you have milk allergy, lactose intolerance, vegan habits, or just don’t like milk, you may require supplements, to reach a daily intake of 800-1000 mg.

4) Vitamin D: This plays a crucial role in bone health, and urban Indians are commonly vitamin D-deficient. Increasing sunlight exposure can be a challenge because of the heat in summer and pollution in winter. Please make sure that you use vitamin D fortified milk products and take supplements as directed (1000-2000 IU/day).

5) Dietary protein: Proteins are important for our bones and critical for our muscle mass. Indian diets are often low in protein. Next time you visit the nutritionist/educator, don’t just discuss sweets. Find out ways to enhance your protein intake, to achieve at least 0.8gm/ kg of body weight daily.

5) Exercise: All kinds of exercise help in strengthening our muscles and bones, but weight-bearing exercises (exercising in erect posture) and resistance-training are the most effective.

6) Giving up smoking and controlling alcohol intake help keep our bones healthy.

7) Medication: If your doctor decides you need medication for your bones, even if you do not have any symptoms, please comply. It is similar to treating high BP, cholesterol or sugar, all of which produce no symptoms but can insidiously lead to long-term complications. Modern medication can reduce your fracture risk by half.

If you follow these principles, you can save your bones and reduce your fracture risk considerably.

Source link

Patient-supporter training improved patient confidence in managing diabetes

Diabetes News
Patient-supporter training improved patient confidence in managing diabetes

1. In this randomized control trial, providing positive support technique training to patient-supporter dyads was associated with greater patient confidence in managing diabetes.

2. However, increased patient supporter engagement did not lead to significant changes in physiological outcomes.

Evidence Rating Level: 1 (Excellent)

Diabetes is a highly prevalent health condition; however, more than 75% of adults with diabetes in the United States do not meet targets blood pressure, glycemic, or lipid control. Although support from a patient’s family and friends may help facilitate diabetic management, interventions which provided diabetes information to family supporters have not been shown to improve patient outcomes. However, the effectiveness of specific training in positive support techniques has not been tested.

This randomized control trial was conducted at two different United States Veterans Health primary care sites. Patients included in this study were aged 30 to 70 years with type 2 diabetes and hemoglobin A1c (HbA1c) greater than 8%, or systolic blood pressure (SBP) higher than 150mmHg. Patients with a life-limiting illness, serious mental illness, active substance use disorder, or those living in a nursing home were excluded. Each patient had an adult supporter. 239 patient-supporter dyads were randomized 1:1 to intervention or standard care and followed for 12 to 15 months. The intervention group received health coaching sessions focused on positive support techniques, while standard of care included general diabetes education materials. The primary outcome was change in patient confidence in managing diabetes, as measured by the Patient Activation Measure-13 (PAM-13) survey and diabetes-specific cardiac event risk score measured by the UK Prospective Diabetes Study (UKPDS). Secondary outcomes included changes in HbA1c, SBP, and diabetes self-management behavior.

Results demonstrated that dyads in the intervention group had greater improvement in PAM-13 score compared to the control group. However, there were no significant differences in 5-year cardiac event risk score or other physiological outcomes between groups. This study was limited by the generalizability given the demographic of patients within the Veterans Health system. Nonetheless, these results suggest that increasing patient supporters’ engagement in care of adults with diabetes is feasible and can improve key patient behavioral outcomes.

Click to read the study in JAMA Network Open 

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Source link

‘Cold wave increases hospitalization, death among diabetes patients’

Diabetes News

A research team at Ajou University School of Medicine has found that the cold wave during the winter season increases the number of hospitalizations and death among diabetes patients.

An Ajou University School of Medicine research team, led by professor Kim Kyoung-nam of preventive medicine, has found that cold weather increases the hospitalization rate and death of diabetes patients.
An Ajou University School of Medicine research team, led by professor Kim Kyoung-nam of preventive medicine, has found that cold weather increases the hospitalization rate and death of diabetes patients.

The team, led by Professor Kim Kyoung-nam of the Department of Preventive Medicine and Public Health, analyzed the hospitalization and death data among diabetes patients that occurred during the three weeks following the onset of a cold wave. They used two kinds of data — insurance claim data from the National Health Insurance Service and deaths from Statistics Korea.

Professor Kim’s team used a Quasi-Poisson regressions model for time-series data analysis to estimate the association between hospitalizations and deaths due to cold and diabetes by region across the country, and then calculated a national estimate through meta-analysis.

The team defined a cold wave as cases where the average temperature was below the bottom 5 percent for more than two days for five months from November 2021 to March 2022 by region.

As a result, hospitalization and death increased by 1.45 and 2.02 times, respectively, over the three weeks after the cold wave occurred, compared to the non-cold wave period, among diabetes patients. 

The team also confirmed that the stronger the cold wave and the longer the duration, the higher the hospitalization and mortality rate among diabetes patients.

Although further studies are required, the research team stressed that it believes that diabetic patients are more vulnerable to cold because peripheral vasoconstriction is not sufficient when exposed to cold, and their ability to regulate body temperature is reduced.

“While there is a lot of social interest in heat waves due to climate change, we estimate that the health impact from cold waves or low temperatures is greater in mid-latitude regions including Seoul, Shanghai, and New York,” Professor Kim said. “Considering that the number of elderly and diabetics who are particularly sensitive to cold or low temperatures is increasing worldwide, continuous attention and preparation for cold or low weathers are necessary.”

The team hopes that this study will help diabetic patients cope with cold waves or low temperatures that will become more frequent and stronger in the future due to climate change and help shape efficient public health policies, Kim added.

The research, titled Associations between cold spells and hospital admission and mortality due to diabetes: A nationwide multi-region time-series study in Korea,” was published in Science of The Total Environment in September.

Source link

Diabetes Diet: How To Make Oats Khichdi To Manage Blood Sugar Levels

Diabetes News

Khichdi is the ultimate comfort food for all Indians. Whether we are exhausted after a long day at work, have an upset stomach, or simply crave something light and wholesome, khichdi has been a saviour for us on many such days. This one-pot dish is not only super easy to make but it is brimming with various health benefits too. The combination of rice, lentils and ghee provides you with carbohydrates and protein that help you keep full for a longer period of time. Not only this but khichdi is also considered to be suitable for people who are suffering from diabetes as it has a low glycaemic index. Considering this, here we bring you a delicious oats khichdi recipe that is ideal for a wholesome lunch meal. 

Also read: Diabetes Diet Tips: 5 Herbs And Spices That May Help Manage Blood Sugar

Oats, the main ingredient in this recipe, has high water and fibre content and may help in managing blood sugar levels. This oats khichdi makes for a nutritious meal and will keep you full for a longer period of time. To make this khichdi, all you need to do is cook oats, moong dal, tomatoes and onions in a pressure cooker along with flavourful masalas. Garnish with fresh coriander leaves and serve hot with yogurt. Take a look at the recipe below:


Oats Khichdi Recipe: How To Make Oats Khichdi

To begin with the recipe, first, heat oil in a pressure cooker. Add cumin seeds and allow them to crackle. Add chopped onion, and cook till translucent. Now, add ginger and green chillies, and cook for a few more seconds. Add turmeric powder and red chilli powder, followed by tomatoes. Let them cook until tender.

Next, add all the vegetables and rinsed moong dal along with oats. Saut&#233; for a few seconds. Add water and adjust the salt. Pressure cook for around 8-10 minutes. Once the pressure settles down, open the lid, serve hot and enjoy! 

For the complete recipe of oats khichdi, click here.

For more khichdi recipes, click here.

Try this simple recipe to manage blood sugar levels at home and share your experience in the comments section below.

Featured Video Of The Day

Gajar Matar Khichdi Recipe | How To Make Gajar Matar Khichdi

Source link

Innovative treatment prevents development of diabetes

Diabetes News

Newswise — Researchers from the Liston lab, at the Babraham Institute, have recently published a preventative therapeutic for diabetes in mice. The team has been able to prevent diabetes in mice by manipulating signalling pathways in pancreatic cells to prevent stress-induced cell death. The treatment targets a pathway common to both major types of diabetes and therefore could have huge therapeutic potential once translated into a clinical treatment.

Dr Kailsah Singh, former research fellow in the Liston lab, described their findings: “Our results show that MANF could prevent the beta cell damage by preventing the inflammation in islets, which is a hallmark of type 1 diabetes.”

For over 35 years there have been failed attempts to prevent type 1 diabetes development. Previous approaches have sought to target the autoimmune nature of the disease, but Dr Adrian Liston, senior Group Leader in the Immunology research programme, wanted to investigate if there was more causing the deterioration in later stages than just the immune response.

The Liston lab sought to understand the role of cell death in the development of diabetes and therefore approached this problem by identifying the pathways that decide whether stressed insulin-producing cells of the pancreas live or die, and therefore determine the development of disease.

Their hope was to find a way to stop this stress-related death, preventing the decline into diabetes without the need to focus solely on the immune system. First, the researchers had to know which pathways would influence the decision of life or death for the beta cell. In previous research, they were able to identify Manf as a protective protein against stress induced cell death, and Glis3 which sets the level of Manf in the cells. While type 1 and 2 diabetes in patients usually have different causes and different genetics, the GLIS3-MANF pathway is a common feature for both conditions and therefore an attractive target for treatments.

In order to manipulate the Manf pathway, the researchers developed a gene delivery system based on a modified virus known as an AAV gene delivery system. The AAV targets beta cells, and allows these cells to make more of the pro-survival protein Manf, tipping the life-or-death decision in favour of continued survival. To test their treatment, the researchers treated mice susceptible to spontaneous development of autoimmune diabetes. Treating pre-diabetic mice resulted in a lower rate of diabetes development from 58% to 18%. This research in mice is a key first step in the development of treatments for human patients.

“A key advantage of targeting this particular pathway is the high likelihood that it works in both type 1 and type 2 diabetes”, explains Dr Adrian Liston. “In type 2 diabetes, while the initial problem is insulin-insensitivity in the liver, most of the severe complications arise in patients where the beta cells of the pancreas have been chronically stressed by the need to make more and more insulin. By treating early type 2 diabetes with this approach, or a similar one, we have the potential to block progression to the major adverse events in late-stage type 2 diabetes.”

Source link

Lions Clubs grants provide diabetes education for 10,000 school nurses and school personnel

Diabetes News

Diabetes in youth, both type 1 and type 2, are on the rise, and as studies show this trend is expected to continue. School nurses and school staff, alike, need to be aware of the needs of children with diabetes and be prepared to meet those needs in the education environment. Laws governing this are set by both the federal government and the Code of Virginia.

The Virginia Code requires that training be offered to school staff who care for students with diabetes. It was recognized that not all schools had access to quality training due to geographic location or limited resources. Changes in diabetic treatment/regimens as well as advancing new technologies make it especially important that quality training be made available.

The Virginia Diabetes Council Schools Committee recognized this need and in partnership with like-interest community groups has successfully launched a diabetes e-learning program, “Lions Empowering and Aiding Regional Nurses in Schools,” that is now being used by school divisions throughout the commonwealth. With financial grant support of the Lions Club International and Lions Club 24L, the pilot program began in the 2019–20 school year. Initially, Lions Club enrolled 2,872 participants and as of October 2022 has enrolled 10,000 participants. Nine hundred seventy-five schools are enrolled in the program with 70 school districts participating, as well as private and parochial schools.

People are also reading…

This training program offers current information about diabetes and best practices for the care of students living with diabetes. Salus Education’s “Diabetes Care at School: Bridging the Gap” is a comprehensive program that addresses basic diabetes awareness information for the school staff, as well as in-depth, technical information directed to those who have responsibility of the child during school activities. Continuing education credits for nurses and school personnel are available. The training has been approved by the Virginia Board of Nursing.

Those completing the training include administrators, nurses, bus drivers, cafeteria workers, athletic directors, trainers, coaches, choir and band directors, teachers and office staff. Some schools have adopted the program and include it as part of their orientation. Some make the training mandatory annually.

The program has been successful even beyond the walls of the schools. Participants have said they have a better understanding of their own diabetes, and their family members and are very glad they took the training.

Providing feedback about the program, a user responded, “I think this was very useful and designed with the learner in mind. Because something like diabetes is life threatening the subject can be scary to ask questions or to take the time to really understand. This self-paced computer program lowered my level of stress while allowing me to review and study at a pace comfortable to me.”

VDC partners include Lions Club International, Lions Club District 24L, Virginia Department of Education, Virginia Department of Health and the Virginia Coordinating Body of Diabetes Care.

Source link

1 2 3